Press Releases
Publications & Presentations
Events
Press Releases
October 28, 2024
EXpressCTSM adapts RNA-based gene expression signatures to cell-free DNA liquid biopsy samples to provide deeper insight beyond DNA mutations GeneCentric to present platform details at the 2024 SU2C Innovation Summit: Cancer Detection…
October 1, 2024
Study utilized GeneCentric’s RNA-based FGFR Predictive Response Signature (FGFR-PRS) and showed it could identify twice as many patients with an activated FGFR pathway compared to patients with FGFR DNA alteration biomarkers Durham,…
July 24, 2024
PurIST® is an RNA expression-based test licensed to Tempus AI to help inform and personalize treatment for patients with pancreatic cancer The PurIST® proprietary laboratory analysis (PLA) code is the first common…
May 20, 2024
Durham, NC, May 20, 2024 – GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, today announced upcoming presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting…
April 1, 2024
Durham, NC, April 1, 2024 – GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, today announced upcoming presentations at the American Association for Cancer Research Annual Meeting 2024 being…
January 22, 2024
Durham, NC, January 22, 2024 – GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, today announced upcoming presentations at the Precision Medicine World Conference (PMWC) in Santa Clara, California…
November 14, 2023
Durham, NC, November 14, 2023 – GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, today announced the appointment of Prasanth Reddy, MD, MPH, FACP, and Don Hardison as independent…
July 20, 2023
The Piedmont Study, a Real-World Data Analysis in Patients Treated with Platinum Doublet Chemotherapy and/or Pembrolizumab, Identifies Predictive Biomarkers for Approved First-Line Treatments in NSCLC Durham, N.C., July 20, 2023 – GeneCentric…
May 31, 2023
PurIST® is an RNA expression-based test for pancreatic cancer molecular subtyping that can help inform and personalize cancer treatment Durham, N.C., May 31, 2023 – GeneCentric Therapeutics, a company making precision medicine…
May 16, 2023
The Alamance study will evaluate a novel FGFR Predictive Response Signature in development to personalize cancer treatment Durham, N.C., May 16, 2023 – GeneCentric Therapeutics, a company making precision medicine more precise…
Publications & Presentations
Events
2024 ASCO Annual Meeting May 31st – June 4th | Chicago, IL
Date of Event: June 2, 2024
GeneCentric presentations include new clinical validation results for a novel signature identifying patients with head and neck squamous cell carcinoma (HNSCC) that may benefit from treatment beyond typical surgical resection. The results…
2024 AACR Annual Meeting – Apr. 5-10, 2024 | San Diego, CA
Date of Event: April 5, 2024
GeneCentric will present two posters, including data on PurIST for pancreatic ductal adenocarcinoma and our new diagnostic program for colorectal cancer, at the AACR Annual Meeting to be held April 5-10, 2024…
31st International Precision Med TRI-CON – Mar. 26-28, 2024 | San Diego, CA
Date of Event: March 26, 2024
GeneCentric will be attending Precision Med TRI-CON to be held March 26-28, 2024 in San Diego, CA. Please reach out ([email protected]) if you would like to schedule a 1:1 meeting with our…
2024 ASCO Genitourinary Cancers Symposium – Jan. 25-27, 2024 | San Francisco, CA
Date of Event: January 25, 2023
GeneCentric will be attending the 20th annual ASCO GU Symposium to be held January 25-27, 2024 in San Francisco, CA. In addition to attending the meeting, we will also be presenting two…
Precision Medicine World Conference – Jan. 24-26, 2024 | Silicon Valley, CA
Date of Event: January 24, 2023
GeneCentric will be attending the annual Precision Medicine World Conference to be held January 24-26, 2024 in Silicon Valley, CA. We will also be giving two talks at PMWC. Please reach out…
JP Morgan Health Conference – Jan. 8-11, 2024 | San Francisco, CA
Date of Event: January 8, 2023
GeneCentric will be attending the annual JP Morgan Health Care Conference to be held January 8-11, 2024 in San Francisco, CA. Please reach out ([email protected]) if you would like to schedule a…
8th Annual Biomarker & Companion Diagnostics Conference – Feb. 8-9, 2023 | San Diego, CA
Date of Event: February 8, 2023
GeneCentric is a proud sponsor of the 8th Annual MarketsandMarkets Biomarker & Companion Diagnostics Conference to be held February 8-9, 2023 in San Diego, CA. Experts from academia and industry will present…